Researchers examined whether large and small bowel resections were associated with developing type 2 diabetes among patients with IBD.
Researchers examined the simultaneous effects of liver fibrosis and sarcopenia on endothelial function and arterial stiffness in type 2 diabetes.
Investigators examined the effect of canagliflozin in patients with both type 2 diabetes and peripheral artery disease.
Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
Eldecalcitol does not reduce the incidence of type 2 diabetes among adults with impaired glucose tolerance.
Neither lifestyle intervention nor metformin reduced major cardiovascular events in adults with prediabetes during the 21-year DPPOS.
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.